Novo Holdings Pulmonx Corp Transaction History

Novo Holdings

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$14.0 - $27.95 $1.41 Million - $2.81 Million	100,400 Added 24.48%	510,555 $7.52 Million
Q1 2022 May 16, 2022	BUY	$21.13 - $35.65 $3.45 Million - $5.81 Million	163,108 Added 66.02%	410,155 $10.2 Million
Q3 2021 Nov 15, 2021	BUY	$35.98 - $44.48 $2.16 Million - $2.67 Million	60,000 Added 32.08%	247,047 $8.89 Million
Q4 2020 Feb 16, 2021	BUY	$39.31 - $69.02 $7.35 Million - $12.9 Million	187,047 New	187,047 $12.9 Million

123

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

Stay updated on Novo Holdings with notifications on news.